| Overview |
| bsm-62714r-Cy5.5-100ul |
| Human IgG Recombinant Antibody, Cy5.5 Conjugated |
| WB, IF |
| Human |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Human IgG |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| P01857,P01859,P01860,P01861 |
| G1m marker; G2m marker; G3m marker; G4m marker; HDC; Heavy chain disease protein; Human immunglobulin G; Ig gamma 1 chain C region; Ig gamma 2 chain C region; Ig gamma 3 chain C region; Ig gamma 4 chain C region; IgG heavy chain locus; IGHG1; IGHG2; IGHG3; IGHG4. |
| Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz